Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Medium RiskFDA Device
Medical Devices/Surgical Equipment

Leksell Vantage Stereotactic System Recalled for Paint Flake Risk

Agency Publication Date: November 5, 2025
Share:
Sign in to monitor this recall

Summary

Elekta, Inc. has recalled 338 units of the Leksell Vantage Stereotactic System because paint flakes from engravings on the device may detach. If these flakes separate during a procedure, there is a possibility they could accidentally enter a patient's surgical wound. This system is used for precise head positioning during neurosurgical procedures like deep brain stimulation, biopsies, and tumor treatments.

Risk

If paint flakes enter a surgical wound during brain surgery, it could lead to complications such as infection, inflammation, or other adverse tissue reactions.

What You Should Do

  1. This recall affects the Leksell Vantage Stereotactic System, specifically the Arc and Support Arc components with serial numbers SH00001 through SH00338.
  2. Check your device for UDI numbers 07340048304856 (Arc) or 07340048304849 (Support Arc).
  3. Stop using the recalled device. Contact the manufacturer, Elekta, Inc., or your distributor to arrange for a return, replacement, or correction of the affected parts.
  4. Call the FDA at 1-888-463-6332 (1-888-INFO-FDA) or visit www.fda.gov/medical-devices/medical-device-recalls for additional information.

Your Remedy Options

📋Other Action
How to: Stop using the recalled device. Contact the manufacturer or your distributor to arrange return, replacement, or correction.

Affected Products

Product: Leksell Vantage Stereotactic System
Variants: Arc, Support Arc
Serial Numbers:
SH00001-SH00338
UDI:
07340048304856
07340048304849

The Intended Purpose is target localization and fixation of the patient head in a coordinate system in order to perform stereotactic neurosurgical procedures.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 97705
Status: Active
Manufacturer: Elekta, Inc.
Sold By: Hospitals; Surgical Centers; Medical Distributors
Manufactured In: United States
Units Affected: 338
Distributed To: Arkansas, California, Colorado, Florida, Idaho, Illinois, Louisiana, Massachusetts, Michigan, Montana, North Carolina, Nebraska, New Hampshire, New Jersey, New Mexico, Nevada, New York, Ohio, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Washington, Wisconsin, West Virginia

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.